ToxSci Advance Access originally published online on November 4, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 77, 347-357 (2004)
Copyright © 2004 by the Society of Toxicology
RESPIRATORY TOXICOLOGY |
Pulmonary Responses of Mice, Rats, and Hamsters to Subchronic Inhalation of Ultrafine Titanium Dioxide Particles
* CIIT Centers for Health Research, Research Triangle Park, North Carolina 27709;
Syngenta, Macclesfield, Cheshire, England SK10 4TJ;
DuPont Haskell Laboratories, Newark, Delaware 19714; and
GlaxoSmithKline, Research Triangle Park, North Carolina 27709
A multispecies, subchronic, inhalation study comparing pulmonary responses to ultrafine titanium dioxide (uf-TiO2) was performed. Female rats, mice, and hamsters were exposed to aerosol concentrations of 0.5, 2.0, or 10 mg/m3 uf-TiO2 particles for 6 h/day, 5 days/week, for 13 weeks. Following the exposure period, animals were held for recovery periods of 4, 13, 26, or 52 weeks (49 weeks for the uf-TiO2–exposed hamsters) and, at each time point, uf-TiO2 burdens in the lung and lymph nodes and selected lung responses were examined. The responses studied were chosen to assess a variety of pulmonary parameters, including inflammation, cytotoxicity, lung cell proliferation, and histopathological alterations. Retained lung burdens increased in a dose-dependent manner in all three species and were at a maximum at the end of exposures. Mice and rats had similar retained lung burdens at the end of the exposures when expressed as mg uf-TiO2/mg dry lung, whereas hamsters had retained lung burdens that were significantly lower. Lung burdens in all three species decreased with time after exposure, and, at the end of the recovery period, the percentage of the lung particle burden remaining in the 10 mg/m3 group was 57, 45, and 3% for rat, mouse, and hamster, respectively. The retardation of particle clearance from the lungs in mice and rats of the 10 mg/m3 group indicated that pulmonary particle overload had been achieved in these animals. Pulmonary inflammation in rats and mice exposed to 10 mg/m3 was evidenced by increased numbers of macrophages and neutrophils and increased concentrations of soluble markers in bronchoalveolar lavage fluid (BALF). The initial neutrophil response in rats was greater than in mice, whereas the relative increase of macrophages was less than in mice. The neutrophilic response of rats, but not mice, declined in a time-dependent manner correlating with declining lung burdens; however, the fraction of recovered neutrophils at 52 weeks postexposure was equivalent in the two species. Consistent increases in soluble indicators of toxicity in the BALF (LDH and protein) occurred principally in rats and mice exposed to 10 mg/m3 and diminished with time postexposure. There were no significant changes in cellular response or with markers indicating toxicity in hamsters, reflecting the capacity of these animals to rapidly clear particles from the lung. Progressive epithelial and fibroproliferative changes were observed in rats of the 10 mg/m3 group. These lesions consisted of foci of alveolar epithelial proliferation of metaplastic epithelial cells (so-called alveolar bronchiolization) circumscribing aggregated foci of heavily particle-laden macrophages. The observed epithelial proliferative changes were also manifested in rats as an increase in alveolar epithelial cell labeling in cell proliferation studies. Associated with these foci of epithelial proliferation were interstitial particle accumulation and alveolar septal fibrosis. These lesions became more pronounced with increasing time postexposure. Epithelial, metaplastic, and fibroproliferative changes were not noted in either mice or hamsters. In summary, there were significant species differences in the pulmonary responses to inhaled uf-TiO2 particles. Under conditions where the lung uf-TiO2 burdens were equivalent, rats developed a more severe inflammatory response than mice and, subsequently, developed progressive epithelial and fibroproliferative changes. Clearance of particles from the lung was markedly impaired in mice and rats exposed to 10 mg/m3 uf-TiO2, whereas clearance in hamsters did not appear to be affected at any of the administered doses. These data are consistent with the results of a companion study using inhaled pigmentary (fine mode) TiO2 (Bermudez et al., 2002) and demonstrate that the pulmonary responses of rats exposed to ultrafine particulate concentrations likely to induce pulmonary overload are different from similarly exposed mice and hamsters. These differences can be explained both by pulmonary response and by particle dosimetry differences among these rodent species.
Key Words: ultrafine titanium dioxide; inhalation; lung response; rats; mice; hamsters.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. M. Scown, R. van Aerle, B. D. Johnston, S. Cumberland, J. R. Lead, R. Owen, and C. R. Tyler High Doses of Intravenously Administered Titanium Dioxide Nanoparticles Accumulate in the Kidneys of Rainbow Trout but with no Observable Impairment of Renal Function Toxicol. Sci., June 1, 2009; 109(2): 372 - 380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pauluhn Pulmonary Toxicity and Fate of Agglomerated 10 and 40 nm Aluminum Oxyhydroxides following 4-Week Inhalation Exposure of Rats: Toxic Effects are Determined by Agglomerated, not Primary Particle Size Toxicol. Sci., May 1, 2009; 109(1): 152 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yanagisawa, H. Takano, K.-i. Inoue, E. Koike, T. Kamachi, K. Sadakane, and T. Ichinose Titanium Dioxide Nanoparticles Aggravate Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice Experimental Biology and Medicine, March 1, 2009; 234(3): 314 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Waters, L. M. Masiello, R. C. Zangar, B. J. Tarasevich, N. J. Karin, R. D. Quesenberry, S. Bandyopadhyay, J. G. Teeguarden, J. G. Pounds, and B. D. Thrall Macrophage Responses to Silica Nanoparticles are Highly Conserved Across Particle Sizes Toxicol. Sci., February 1, 2009; 107(2): 553 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Card, D. C. Zeldin, J. C. Bonner, and E. R. Nestmann Pulmonary applications and toxicity of engineered nanoparticles Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L400 - L411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Rouse, G. Murphy, M. J. Boudreaux, D. B. Paulsen, and A. L. Penn Soot Nanoparticles Promote Biotransformation, Oxidative Stress, and Inflammation in Murine Lungs Am. J. Respir. Cell Mol. Biol., August 1, 2008; 39(2): 198 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Stern and S. E. McNeil Nanotechnology Safety Concerns Revisited Toxicol. Sci., January 1, 2008; 101(1): 4 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. MAYNARD Nanotechnology: The Next Big Thing, or Much Ado about Nothing? Ann. Hyg., January 1, 2007; 51(1): 1 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lin, Y.-w. Huang, X.-D. Zhou, and Y. Ma Toxicity of Cerium Oxide Nanoparticles in Human Lung Cancer Cells International Journal of Toxicology, November 1, 2006; 25(6): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sydlik, K. Bierhals, M. Soufi, J. Abel, R. P. F. Schins, and K. Unfried Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L725 - L733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Warheit, T. R. Webb, C. M. Sayes, V. L. Colvin, and K. L. Reed Pulmonary Instillation Studies with Nanoscale TiO2 Rods and Dots in Rats: Toxicity Is not Dependent upon Particle Size and Surface Area Toxicol. Sci., May 1, 2006; 91(1): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Tsuji, A. D. Maynard, P. C. Howard, J. T. James, C.-w. Lam, D. B. Warheit, and A. B. Santamaria Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles Toxicol. Sci., January 1, 2006; 89(1): 42 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Elder, R. Gelein, J. N. Finkelstein, K. E. Driscoll, J. Harkema, and G. Oberdorster Effects of Subchronically Inhaled Carbon Black in Three Species. I. Retention Kinetics, Lung Inflammation, and Histopathology Toxicol. Sci., December 1, 2005; 88(2): 614 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Holsapple, W. H. Farland, T. D. Landry, N. A. Monteiro-Riviere, J. M. Carter, N. J. Walker, and K. V. Thomas Research Strategies for Safety Evaluation of Nanomaterials, Part II: Toxicological and Safety Evaluation of Nanomaterials, Current Challenges and Data Needs Toxicol. Sci., November 1, 2005; 88(1): 12 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. HEXT, J. A. TOMENSON, and P. THOMPSON Titanium Dioxide: Inhalation Toxicology and Epidemiology Ann. Hyg., August 1, 2005; 49(6): 461 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, J. Chen, J. Dong, and Y. Jin Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats Toxicology and Industrial Health, February 1, 2004; 20(1-5): 21 - 27. [Abstract] [PDF]
|
|